EP3352735
SUSTAINED RELEASE OLANZAPINE FORMULATIONS
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
21.9.2016EP published:
30.8.2023EP application number:
16775424.1
EPO information:
European Patent Register
Max expiry date:
20.9.2036
Title in English:
SUSTAINED RELEASE OLANZAPINE FORMULATIONSLanguage of the patent:
English
Timeline
Today
21.9.2016EP application
30.8.2023EP Publication
Owner
Name:
Teva Pharmaceuticals International GmbHAddress:
Schlüsselstrasse 12, 8645 Jona, CH
Inventor
Name:
SMITH, Mark, AlanAddress:
Elkton, MD 21921, US
Name:
CLAASSEN-PUNT, CarineAddress:
2317 LP Leiden, NL
Priority
Number:
201562221290 PDate:
21.9.2015Country:
US
Classification
Categories:
A61K 9/16, A61K 9/00, A61K 47/34, A61K 31/551, A61P 25/18, A61P 25/00